Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|July 11, 2017
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapyKeehoon Jung, Takahiro Heishi, Omar F Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2017
Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancerKeehoon Jung, Takahiro Heishi, Joao Incio, et al.
Nature Biomedical Engineering|October 3, 2017
Solid stress and elastic energy as measures of tumour mechanopathologyHadi T Nia, Hao Liu, Giorgio Seano, et al.
Cancer Cell|August 17, 2010
Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakageYoung Jun Koh, Hak-Zoo Kim, Seong-Ik Hwang, et al.
Science Translational Medicine|October 14, 2016
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastasesNuh N Rahbari, Dmitriy Kedrin, Joao Incio, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophagesTeresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, et al.
Molecular Cancer|February 29, 2024
Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanomaJeongsoo Kim, Tae-Jin Kim, Sehyun Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in ObesityJoao Incio, Josh Tam, Nuh N Rahbari, et al.
Annals of Surgical Oncology|January 23, 2025
High-Throughput Chemotherapeutic Drug Screening System for Gastric Cancer (Cure-GA)Jieun Lee, In Hee Kim, Donghyeok Seol, et al.
Science Translational Medicine|March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
Pageof 5